Mohammed Asif Sheikh, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 52579 Highway 51 S, Independence, LA 70443 Phone: 985-878-9421 Fax: 985-878-1489 |
Tashawn L. Mustiful, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 52579 Highway 51 S, Independence, LA 70443 Phone: 225-654-0522 |
Dr. Cristino C Dijamco, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 52579 Highway 51 S, Independence, LA 70443 Phone: 985-878-9421 Fax: 985-878-1431 |
Catherine M Mccormick, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 52579 Highway 51 S, Independence, LA 70443 Phone: 985-878-1349 Fax: 985-878-1630 |
Dr. George Pierre Desormeaux, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 52579 Highway 51 South, Independence, LA 70443 Phone: 985-878-9421 |
Dr. Charles Raymond Genovese Jr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 312 East Railroad Avenue, Independence, LA 70443 Phone: 985-878-4183 Fax: 985-878-3830 |
Matloob Ur Rehman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 52579 Highway 51 S, Independence, LA 70443 Phone: 985-878-9421 Fax: 985-878-1285 |
Dr. Agustin A Garcia Caballero Monge, M.D. Internal Medicine - Medical Oncology Medicare: Accepting Medicare Assignments Practice Location: 52579 Highway 51 S, Independence, LA 70443 Phone: 985-878-9421 Fax: 985-878-1306 |
News Archive
Researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco, and Pfizer Inc., have determined that two new compounds may be effective in treating both alcohol and nicotine dependence at the same time.
A high body mass index has no significant impact on parameters of sperm quality, although it does lower serum levels of testosterone, luteinizing hormone, and prolactin, say researchers.
Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could-if given early enough-potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection.
The Pulmonary Fibrosis Foundation (PFF) today announced its October schedule of fundraising events as part of its ongoing national campaign to raise funds for pulmonary fibrosis (PF) research, while supporting the PFF's patient education and advocacy efforts throughout the country. The PFF has seen continued expansion of its public support throughout the United States, with more than 40 local and regional fundraisers contributing greatly to the Foundation's total of more than $800,000 in gifts this year.
Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company's proprietary technology, today announced that it raised $20 million in a Series D private equity financing.
› Verified 9 days ago